Interactions between methylating and pyridyloxobutylating agents in A/J mouse lungs: Implications for 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced lung tumorigenesis
La. Peterson et al., Interactions between methylating and pyridyloxobutylating agents in A/J mouse lungs: Implications for 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced lung tumorigenesis, CANCER RES, 61(15), 2001, pp. 5757-5763
The tobacco-specific nitrosamine, 4-(methylnitrosoamino)-1-(3-pyridyl)-1-bu
tanone, is activated to lung DNA methylating and pyridyloxobutylating inter
mediates. It is likely that both pathways play a role in lung tumor initiat
ion by this nitrosamine. Previous studies indicated that O-6-methylguanine
(O-6-mG) persistence is critical for lung tumor formation in A/J mice. The
model pyridyloxobutylating agent, 4-(acetoxymethylnitrosamino)-1-(3-pyridyl
)-1-butanone (NNKOAc), enhanced the tumorigenic activity of a model methyla
ting agent, acetoxymethylmethylnitrosamine (AMMN), presumably by increasing
O-6-mG persistence in lung DNA. We have been testing the hypothesis that t
he pyridyloxobutylation pathway increases the mutagenic activity of the DNA
methylation pathway by preventing the repair of O-6-mG by O-6-alkylguanine
-DNA alkyltransferase (AGT). In this study, we report that NNKOAc depletes
AGT in lungs but not livers of A/J mice. The consequences of AGT depletion
by NNKOAc were then compared with those observed with a known AGT inhibitor
, O-6-benzylguanine (O-6-bG). NNKOAc and O-6-bG had similar effects on the
levels of AMMN-derived O-6-mG at 4 and 96 h postinjection. This increase in
O-6-mG levels correlated to increased lung tumor multiplicity in animals s
imultaneously treated with AMMN (0.75 or 1 mu mol) and NNKOAc or O-6-bG. On
ly NNKOAc significantly increased lung tumor multiplicity at doses of 0.25
or 0.5 mu mol AMMN. The results from these studies indicate that the pyridy
loxobutylating agent, NNKOAc, can influence the tumorigenic activity of met
hylating agents in two ways. At low AMMN doses, the increase in tumor multi
plicity is dominated by the additive tumorigenic properties of AMMN and NNK
OAc. At higher AMMN doses, NNKOAc appears to enhance the tumorigenic activi
ty of AMMN through enhanced depletion of the repair protein, AGT, leading t
o increased O-6-mG persistence. It is likely that similar interactions are
important for the organospecific effects of 4-(methylnitrosoamino)-1-(3-pyr
idyl)-1-butanone.